← Back to Clinical Trials
Recruiting NCT03707691

NCT03707691 Pitch Perception and Memory: Deficits and Training

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT03707691
Status Recruiting
Phase —
Sponsor Hospices Civils de Lyon
Condition Cochlear Implants
Study Type INTERVENTIONAL
Enrollment 960 participants
Start Date 2019-11-26
Primary Completion 2029-11-26

Eligibility & Interventions

Sex All sexes
Min Age 5 Years
Max Age 90 Years
Study Type INTERVENTIONAL
Interventions
Listening tests. Pitch training protocolvisuo-spatial training protocolEEG/MEG/MRI recordings.

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 960 participants in total. It began in 2019-11-26 with a primary completion date of 2029-11-26.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Pitch perception and memory are central in auditory cognition, in particular for sound source segregation and recognition, speech prosody and music processing. Here the investigator assess pitch perception and memory in hearing-impaired listeners wearing cochlear implant(s) and listeners with congenital amusia, both compared with control listeners. Behavioral, EEG, and MEG measures are collected in audio and audio-visual contexts to characterize pitch processing deficits, and test a pitch training program.

Eligibility Criteria

Inclusion Criteria: For adult participants: * Aged between 18 and 90 * Absence of neurological and psychiatric disorders * No major cognitive deficit, ability to understand and apply study instructions * Motivation to participate efficiently in the study * Written informed consent to participant in the study * Affiliated to social security * Control participants and participants with congenital amusia for Experiment 5: MRI/MEG compatibility For underage participants: * Subject aged 5 years and over * Informed consent of parents or guardians for the participation of the child being studied * No neurological or psychiatric history * Without major cognitive impairment and ability to understand and apply setpoint. * Subject affiliated to a social security scheme * Motivation to participate effectively in the project Exclusion Criteria: For adult participants: * Age below 18 or above 90 * Pregnant or breast-feeding woman For underage participants: \- Pregnant or nursing minors

Contact & Investigator

Central Contact

Anne CACLIN

✉ anne.caclin@inserm.fr

📞 4 72 13 89 04

Principal Investigator

Anne CACLIN

PRINCIPAL INVESTIGATOR

Hospices Civils de Lyon

Frequently Asked Questions

Who can join the NCT03707691 clinical trial?

This trial is open to participants of all sexes, aged 5 Years or older, up to 90 Years, studying Cochlear Implants. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT03707691 currently recruiting?

Yes, NCT03707691 is actively recruiting participants. Contact the research team at anne.caclin@inserm.fr for enrollment information.

Where is the NCT03707691 trial being conducted?

This trial is being conducted at Bron, France.

Who is sponsoring the NCT03707691 clinical trial?

NCT03707691 is sponsored by Hospices Civils de Lyon. The principal investigator is Anne CACLIN at Hospices Civils de Lyon. The trial plans to enroll 960 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology